Impact of Aluminium phthalocyanine nanoconjugate on melanoma stem cells
Source abstract
Abstract
Metastatic melanoma cancer stem cells are subpopulations linked to tumour development, immunoevasive behaviour, treatment resistance, and metastasis, all of which contribute to a poor prognosis. Photodynamic treatment (PDT) is an alternate strategy to cancer eradication that involves the generation of reactive oxygen species. As a carrier, nanoparticles enable efficient cellular uptake of photosensitizers, improving organelle accumulation and cancer cell targeted therapy. This study considered at the effect of PDT on CD133+ Melanoma Stem Cells utilising an Aluminium Phthalocyanine Gold Nanoparticle (AlPcS4Cl-AuNP) combination. A ligand exchange approach was used to conjugate AlPcS4Cl–PEG-AuNP-COOH and was characterised using UV-Vis, FTIR, DLS and Zeta Potential. Stem cells isolated from the A375 cell line irradiated with a laser at 673.2 nm with a fluency of 5 J/cm2 were evaluated. Furthermore, it was important to study if apoptosis was one of the mechanisms causing to cell death which was substantiated with Annexin V/PI, caspase 3 and p53 analysis. The nanoparticle conjugate mediated PDT promoted apoptotic cell death, showing increased expression of p53 and caspase-3. The study proposed a strategy aimed at extending the understanding of PDT in enhancing the therapy of melanoma, suggesting a probable improved cell death when AlPcS4Cl was conjugated to AuNPs.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, Doornfontein, South Africa
Funding
South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation of South Africa · CSIR-DSI Council · Faculty of Health Sciences Supervisor Linked Bursary
References (74)
Show source-provided references
1. 10.1200/JCO.2001.19.16.362210.1200/JCO.2001.19.16.3622 ↗
2. Ferlay J, Ervik M, Lam F, et al. Global cancer observatory: cancerToday, Lyon: International Agency for Research on Cancer; 2021, https://gco.iarc.fr/today.
3. 10.1111/j.1755-148X.2007.00427.x10.1111/j.1755-148X.2007.00427.x ↗
4. 10.1038/sj.bjc.660608410.1038/sj.bjc.6606084 ↗
5. 10.1038/nature1121910.1038/nature11219 ↗
6. 10.1093/annonc/mdv29710.1093/annonc/mdv297 ↗
7. 10.4149/neo_2016_40310.4149/neo_2016_403 ↗
8. 10.1002/ijc.3070810.1002/ijc.30708 ↗
9. 10.1177/153303381879179510.1177/1533033818791795 ↗
10. 10.1016/j.ejca.2015.11.01610.1016/j.ejca.2015.11.016 ↗
11. 10.1038/nature1262410.1038/nature12624 ↗
12. 10.1038/nature0756710.1038/nature07567 ↗
13. 10.1016/j.cell.2006.07.02410.1016/j.cell.2006.07.024 ↗
14. 10.1038/ncb182610.1038/ncb1826 ↗
15. 10.1038/s41598-019-42773-y10.1038/s41598-019-42773-y ↗
16. 10.1038/2529210.1038/25292 ↗
17. 10.1002/sctm.17-022310.1002/sctm.17-0223 ↗
18. 10.1186/s40169-018-0198110.1186/s40169-018-01981 ↗
19. 10.4252/wjsc.v10.i12.18310.4252/wjsc.v10.i12.183 ↗
20. 10.3390/jcm810158110.3390/jcm8101581 ↗
21. 10.1158/0008-5472.CAN-19-020110.1158/0008-5472.CAN-19-0201 ↗
22. 10.1002/adhm.20190013210.1002/adhm.201900132 ↗
23. 10.1097/DSS.000000000000080010.1097/DSS.0000000000000800 ↗
24. 10.6004/jnccn.2016.006510.6004/jnccn.2016.0065 ↗
25. 10.1016/j.adengl.2015.07.01910.1016/j.adengl.2015.07.019 ↗
26. 10.1016/s1011-1344(01)00206-810.1016/s1011-1344(01)00206-8 ↗
27. 10.1016/j.jconrel.2019.12.05210.1016/j.jconrel.2019.12.052 ↗
28. 10.1016/j.pdpdt.2020.10166310.1016/j.pdpdt.2020.101663 ↗
29. 10.1039/b915149b10.1039/b915149b ↗
30. 10.1021/am500106c10.1021/am500106c ↗
31. 10.1016/j.apsb.2016.01.00710.1016/j.apsb.2016.01.007 ↗
32. 10.1039/C8PP00271A10.1039/C8PP00271A ↗
33. 10.3109/21691401.2016.116769710.3109/21691401.2016.1167697 ↗
34. 10.1016/j.freeradbiomed.2011.05.02310.1016/j.freeradbiomed.2011.05.023 ↗
35. 10.2147/IJN.S6337110.2147/IJN.S63371 ↗
36. 10.1016/j.redox.2018.11.01410.1016/j.redox.2018.11.014 ↗
37. 10.1038/nrm380110.1038/nrm3801 ↗
38. 10.1002/advs.20180205710.1002/advs.201802057 ↗
39. 10.3892/ol.2021.1282710.3892/ol.2021.12827 ↗
40. 10.1038/sj.bjc.660485610.1038/sj.bjc.6604856 ↗
41. 10.1126/scisignal.200305710.1126/scisignal.2003057 ↗
42. 10.1002/jcp.2947910.1002/jcp.29479 ↗
43. 10.1016/j.arabjc.2020.10.01410.1016/j.arabjc.2020.10.014 ↗
44. 10.1016/j.jlumin.2017.11.04710.1016/j.jlumin.2017.11.047 ↗
45. Decker R, Oldenburg S. Covalent Bioconjugation of Antibodies to Carboxyl Terminated Nanoparticles PDF Protein Purification Nanoparticle https://www.scribd.com/document/511702433/Decker-R-Oldenburg-S-Covalent-Bioconjugation-of-Antibodies-to-Carboxyl-Terminated-Nanoparticles. (accessed 2021 -10 -25).
46. 10.1039/C5NR05826K10.1039/C5NR05826K ↗
47. 10.1021/jm301311c10.1021/jm301311c ↗
48. 10.1016/j.jphotobiol.2019.03.01810.1016/j.jphotobiol.2019.03.018 ↗
49. 10.1021/bc049951i10.1021/bc049951i ↗
50. 10.1021/ar800035u10.1021/ar800035u ↗
51. 10.1155/2018/429070510.1155/2018/4290705 ↗
52. 10.1038/s41598-018-33271-810.1038/s41598-018-33271-8 ↗
53. 10.3390/cancers1314348410.3390/cancers13143484 ↗
54. 10.3389/fonc.2020.0059710.3389/fonc.2020.00597 ↗
55. 10.1007/s12551-016-0218-610.1007/s12551-016-0218-6 ↗
56. 10.1155/2016/108725010.1155/2016/1087250 ↗
57. 10.3390/pharmaceutics1002005710.3390/pharmaceutics10020057 ↗
58. 10.3390/nano611021610.3390/nano6110216 ↗
59. 10.1007/s10616-012-9481-y10.1007/s10616-012-9481-y ↗
60. 10.3791/259710.3791/2597 ↗
61. 10.1016/j.jphotobiol.2015.07.01910.1016/j.jphotobiol.2015.07.019 ↗
62. 10.3390/pharmaceutics1411247410.3390/pharmaceutics14112474 ↗
63. 10.2147/IJN.S15405410.2147/IJN.S154054 ↗
64. 10.1016/j.jphotochem.2022.11433910.1016/j.jphotochem.2022.114339 ↗
65. 10.1038/sj.cdd.440047610.1038/sj.cdd.4400476 ↗
66. 10.3390/ijms1202104110.3390/ijms12021041 ↗
67. 10.1146/annurev.biochem.68.1.38310.1146/annurev.biochem.68.1.383 ↗
68. 10.1074/jbc.M00836320010.1074/jbc.M008363200 ↗
69. 10.1152/physrev.00013.200610.1152/physrev.00013.2006 ↗
70. 10.1038/sj.onc.120711610.1038/sj.onc.1207116 ↗
71. 10.3390/cancers1110149010.3390/cancers11101490 ↗
72. 10.1155/2019/648617310.1155/2019/6486173 ↗
73. 10.1016/j.canlet.2014.10.04310.1016/j.canlet.2014.10.043 ↗
74. 10.1016/j.canlet.2013.09.02410.1016/j.canlet.2013.09.024 ↗